About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Review of Hematology
›
Top Articles
Expert Review of Hematology
Hematology
2.8
(top 6%)
Impact Factor
3.2
(top 6%)
extended IF
47
(top 9%)
H-Index
876
authors
1.1K
papers
13.2K
citations
2.5K
citing journals
12.8K
citing authors
Most Cited Articles of Expert Review of Hematology
Title
Year
Citations
Mitochondria and Iron: current questions
2017
143
Relapse after allogeneic stem cell transplantation
2010
117
Allogeneic hematopoietic cell transplantation: the state of the art
2010
116
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
2010
109
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field
2012
108
Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders
2010
99
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders
2013
98
Akt signaling in platelets and thrombosis
2010
91
The bone marrow microenvironment and leukemia: biology and therapeutic targeting
2011
87
Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health
2011
84
Immunoglobulin light chain amyloidosis
2014
83
Classification and therapeutic approaches in autoimmune hemolytic anemia: an update
2011
83
Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
2013
81
Complications of thalassemia major and their treatment
2011
81
D-dimer level in COVID-19 infection: a systematic review
2020
78
Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up
2011
75
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
2019
74
CXCL12 and CXCR4 in bone marrow physiology
2010
74
Management of bone disease in multiple myeloma
2014
73
Strategies to enhance umbilical cord blood stem cell engraftment in adult patients
2010
72
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
2010
65
Fondaparinux: does it cause HIT? Can it treat HIT?
2010
65
Why factor XI deficiency is a clinical concern
2016
65
Transfusion immunomodulation from a clinical perspective: an update
2013
62
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
2017
60
previous
2012
2013
2014
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.